Modulari-T vs Ochre Bio

<p>Modulari-T provides cutting-edge biotechnology software solutions centered on Modular Actuation Receptor Cells (MARC), which are synthetic immune receptors designed for high efficacy and safety across diverse cell types. It enables you to leverage these receptors to improve immune cell therapies by preventing early T cell exhaustion and enhancing their persistence, making cell therapies more functional and long-lasting.</p> <p>With Modulari-T, you also gain access to the Modular Vector (MoVE) platform for in vivo delivery of these engineered receptors, targeting immune cells like T cells and NK cells. This combination offers scalable, off-the-shelf cell therapy options that are backed by peer-reviewed science, making it a promising tool for researchers and healthcare professionals working on cancer immunotherapy and advanced cell therapy development.</p>

<p>Ochre Bio is a cutting-edge platform that combines AI with large-scale human liver data to accelerate drug discovery specifically for chronic liver diseases. It enables you to explore causal disease mechanisms, validate targets in human tissue, and develop RNA therapies in-house, significantly reducing R&amp;D timelines. The platform targets the pharmaceutical industry and research organizations aiming to find effective treatments beyond liver transplants.</p> <p>With investments in proprietary datasets and integrated gene atlases, Ochre Bio supports discovery, validation, and clinical development pipelines. You benefit from access to mechanistic insights, RNA therapeutic development, and partnerships with leading companies like GSK. This platform aims to revolutionize liver disease treatment by making drug development faster and more precise.</p>